Alaunos Therapeutics, Inc. Operating Cash Flow
Alaunos Therapeutics, Inc. (TCRT) reported Operating Cash Flow of -$1.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- Alaunos Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$300.00K.
- Alaunos Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.03M.
- Alaunos Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$552.00K.
- Alaunos Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$844.00K.
- Alaunos Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$2.87M.
- Alaunos Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$4.97M.
- Alaunos Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$30.14M.
- Alaunos Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$29.23M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 85 month | Net Cash Provided by (Used in) Operating Activities 94 month | Net Cash Provided by (Used in) Operating Activities 97 month | Net Cash Provided by (Used in) Operating Activities 100 month | Net Cash Provided by (Used in) Operating Activities 103 month | Net Cash Provided by (Used in) Operating Activities 106 month | Net Cash Provided by (Used in) Operating Activities 109 month | Net Cash Provided by (Used in) Operating Activities 112 month | Net Cash Provided by (Used in) Operating Activities 115 month | Net Cash Provided by (Used in) Operating Activities 118 month | Net Cash Provided by (Used in) Operating Activities 121 month | Net Cash Provided by (Used in) Operating Activities 124 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.33M 10-Q · filed 2026-08-14 | -$1.88M derived: sum of 3 quarters · filed 2026-08-14 | -$2.73M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2026-03-31 | -$1.03M 10-Q · filed 2026-05-15 | -$1.58M derived: sum of 2 quarters · filed 2026-05-15 | -$2.43M derived: sum of 3 quarters · filed 2026-05-15 | -$3.13M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2025-12-31 | -$552.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.40M derived: sum of 2 quarters · filed 2026-03-31 | -$2.10M derived: sum of 3 quarters · filed 2026-08-14 | -$2.87M 10-K · filed 2026-03-31 | ||||||||||||
| 2025-09-30 | -$844.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$1.54M derived: sum of 2 quarters · filed 2026-08-14 | -$2.32M 10-Q · filed 2025-11-14 | -$2.91M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2025-06-30 | -$701.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.47M 10-Q · filed 2026-08-14 | -$2.06M derived: sum of 3 quarters · filed 2026-08-14 | -$2.85M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2025-03-31 | -$772.00K 10-Q · filed 2026-05-15 | -$1.36M derived: sum of 2 quarters · filed 2026-05-15 | -$2.15M derived: sum of 3 quarters · filed 2026-05-15 | -$3.83M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||
| 2024-12-31 | -$592.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.37M derived: sum of 2 quarters · filed 2026-03-31 | -$3.05M derived: sum of 3 quarters · filed 2026-03-31 | -$4.97M 10-K · filed 2026-03-31 | ||||||||||||
| 2024-09-30 | -$781.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.46M derived: sum of 2 quarters · filed 2025-11-14 | -$4.38M 10-Q · filed 2025-11-14 | -$11.76M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||||||
| 2024-06-30 | -$1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$3.60M 10-Q · filed 2025-08-14 | -$10.98M derived: sum of 3 quarters · filed 2025-08-14 | -$17.36M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||||
| 2024-03-31 | -$1.92M 10-Q · filed 2025-05-15 | -$9.30M derived: sum of 2 quarters · filed 2025-05-15 | -$15.68M derived: sum of 3 quarters · filed 2025-05-15 | -$22.68M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||||
| 2023-12-31 | -$7.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$13.76M derived: sum of 2 quarters · filed 2025-03-31 | -$20.76M derived: sum of 3 quarters · filed 2025-03-31 | -$30.14M 10-K · filed 2025-03-31 | ||||||||||||
| 2023-09-30 | -$6.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$13.38M derived: sum of 2 quarters · filed 2024-11-14 | -$22.76M 10-Q · filed 2024-11-14 | -$29.89M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||||
| 2023-06-30 | -$7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$16.38M 10-Q · filed 2024-08-14 | -$23.51M derived: sum of 3 quarters · filed 2024-08-14 | -$29.66M derived: sum of 4 quarters · filed 2024-08-14 | ||||||||||||
| 2023-03-31 | -$9.38M 10-Q · filed 2024-05-15 | -$16.51M derived: sum of 2 quarters · filed 2024-05-15 | -$22.66M derived: sum of 3 quarters · filed 2024-05-15 | -$30.84M derived: sum of 4 quarters · filed 2024-05-15 | ||||||||||||
| 2022-12-31 | -$7.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$13.28M derived: sum of 2 quarters · filed 2024-04-01 | -$21.46M derived: sum of 3 quarters · filed 2024-04-01 | -$29.23M 10-K · filed 2024-04-01 | ||||||||||||
| 2022-09-30 | -$6.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$14.33M derived: sum of 2 quarters · filed 2023-11-14 | -$22.10M 10-Q · filed 2023-11-14 | -$37.23M derived: sum of 4 quarters · filed 2023-11-14 | ||||||||||||
| 2022-06-30 | -$8.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$15.96M 10-Q · filed 2023-08-14 | -$31.08M derived: sum of 3 quarters · filed 2023-08-14 | -$40.66M derived: sum of 4 quarters · filed 2023-08-14 | ||||||||||||
| 2022-03-31 | -$7.77M 10-Q · filed 2023-05-10 | -$22.90M derived: sum of 2 quarters · filed 2023-05-10 | -$32.47M derived: sum of 3 quarters · filed 2023-05-10 | -$53.92M derived: sum of 4 quarters · filed 2023-05-10 | ||||||||||||
| 2021-12-31 | -$15.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$24.70M derived: sum of 2 quarters · filed 2023-03-07 | -$46.16M derived: sum of 3 quarters · filed 2023-03-07 | -$61.47M 10-K · filed 2023-03-07 | ||||||||||||
| 2021-09-30 | -$9.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$31.03M derived: sum of 2 quarters · filed 2022-11-14 | -$46.34M 10-Q · filed 2022-11-14 | -$63.38M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||||
| 2021-06-30 | -$21.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$36.77M 10-Q · filed 2022-08-15 | -$53.80M derived: sum of 3 quarters · filed 2022-08-15 | -$69.87M derived: sum of 4 quarters · filed 2022-08-15 | ||||||||||||
| 2021-03-31 | -$15.31M 10-Q · filed 2022-05-16 | -$32.35M derived: sum of 2 quarters · filed 2022-05-16 | -$48.41M derived: sum of 3 quarters · filed 2022-05-16 | -$62.42M derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||||
| 2020-12-31 | -$17.04M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$33.10M derived: sum of 2 quarters · filed 2022-03-30 | -$47.11M derived: sum of 3 quarters · filed 2022-03-30 | -$57.01M 10-K · filed 2022-03-30 | ||||||||||||
| 2020-09-30 | -$16.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$30.07M derived: sum of 2 quarters · filed 2021-11-08 | -$39.98M 10-Q · filed 2021-11-08 | -$51.59M derived: sum of 4 quarters · filed 2021-11-08 | ||||||||||||
| 2020-06-30 | -$14.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$23.91M 10-Q · filed 2021-08-13 | -$35.52M derived: sum of 3 quarters · filed 2021-08-13 | -$46.45M derived: sum of 4 quarters · filed 2021-08-13 | ||||||||||||
| 2020-03-31 | -$9.91M 10-Q · filed 2021-05-06 | -$21.51M derived: sum of 2 quarters · filed 2021-05-06 | -$32.44M derived: sum of 3 quarters · filed 2021-05-06 | -$40.53M derived: sum of 4 quarters · filed 2021-05-06 | ||||||||||||
| 2019-12-31 | -$11.61M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$22.54M derived: sum of 2 quarters · filed 2021-03-01 | -$30.62M derived: sum of 3 quarters · filed 2021-03-01 | -$40.85M 10-K · filed 2021-03-01 | ||||||||||||
| 2019-09-30 | -$10.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$19.01M derived: sum of 2 quarters · filed 2020-11-05 | -$29.25M 10-Q · filed 2020-11-05 | -$41.06M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||
| 2019-06-30 | -$8.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$18.32M 10-Q · filed 2020-08-06 | -$30.14M derived: sum of 3 quarters · filed 2021-03-01 | -$38.65M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||
| 2019-03-31 | -$10.23M 10-Q · filed 2020-05-07 | -$22.05M derived: sum of 2 quarters · filed 2021-03-01 | -$30.56M derived: sum of 3 quarters · filed 2021-03-01 | -$40.73M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||
| 2018-12-31 | -$11.82M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$20.33M derived: sum of 2 quarters · filed 2021-03-01 | -$30.50M derived: sum of 3 quarters · filed 2021-03-01 | -$49.46M 10-K · filed 2021-03-01 | ||||||||||||
| 2018-09-30 | -$8.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$18.68M derived: sum of 2 quarters · filed 2019-11-07 | -$37.64M 10-Q · filed 2019-11-07 | -$49.79M derived: sum of 4 quarters · filed 2020-03-02 | ||||||||||||
| 2018-06-30 | -$10.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$29.13M 10-Q · filed 2019-08-08 | -$41.29M derived: sum of 3 quarters · filed 2020-03-02 | -$54.00M derived: sum of 4 quarters · filed 2020-03-02 | ||||||||||||
| 2018-03-31 | -$18.96M 10-Q · filed 2019-05-08 | -$31.11M derived: sum of 2 quarters · filed 2020-03-02 | -$43.83M derived: sum of 3 quarters · filed 2020-03-02 | |||||||||||||
| 2017-12-31 | -$12.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$24.87M derived: sum of 2 quarters · filed 2020-03-02 | -$54.67M 10-K · filed 2020-03-02 | |||||||||||||
| 2017-09-30 | -$12.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$42.51M 10-Q · filed 2018-11-09 | ||||||||||||||
| 2017-06-30 | -$29.80M 10-Q · filed 2018-08-08 | |||||||||||||||
| 2016-12-31 | -$58.33M 10-K · filed 2019-03-05 | |||||||||||||||
| 2013-12-31 | -$9.04M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$24.55M derived: sum of 2 quarters · filed 2014-03-03 | -$41.27M derived: sum of 3 quarters · filed 2014-03-03 | -$59.51M 10-K · filed 2014-03-03 | -$281.15M 10-K · filed 2014-03-03 | |||||||||||
| 2013-09-30 | -$15.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22 | -$32.22M derived: sum of 2 quarters · filed 2013-10-22 | -$50.46M 10-Q · filed 2013-10-22 | -$71.96M derived: sum of 4 quarters · filed 2014-03-03 | -$272.10M 10-Q · filed 2013-10-22 | |||||||||||
| 2013-06-30 | -$16.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$34.96M 10-Q · filed 2013-08-08 | -$56.46M derived: sum of 3 quarters · filed 2014-03-03 | -$71.17M derived: sum of 4 quarters · filed 2014-03-03 | -$256.60M 10-Q · filed 2013-08-08 | |||||||||||
| 2013-03-31 | -$18.24M 10-Q · filed 2013-05-07 | -$39.74M derived: sum of 2 quarters · filed 2014-03-03 | -$54.45M derived: sum of 3 quarters · filed 2014-03-03 | -$71.22M derived: sum of 4 quarters · filed 2014-03-03 | -$239.88M 10-Q · filed 2013-05-07 | |||||||||||
| 2012-12-31 | -$21.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$36.21M derived: sum of 2 quarters · filed 2014-03-03 | -$52.97M derived: sum of 3 quarters · filed 2014-03-03 | -$78.83M 10-K · filed 2014-03-03 | -$221.64M 10-K · filed 2013-03-18 | |||||||||||
| 2012-09-30 | -$14.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22 | -$31.47M derived: sum of 2 quarters · filed 2013-10-22 | -$57.33M 10-Q · filed 2013-10-22 | -$71.08M derived: sum of 4 quarters · filed 2014-03-03 | -$200.14M 10-Q · filed 2012-11-08 | |||||||||||
| 2012-06-30 | -$16.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$42.63M 10-Q · filed 2013-08-08 | -$56.38M derived: sum of 3 quarters · filed 2014-03-03 | -$67.47M derived: sum of 4 quarters · filed 2014-03-03 | -$185.43M 10-Q/A · filed 2012-08-28 | |||||||||||
| 2012-03-31 | -$25.86M 10-Q · filed 2013-05-07 | -$39.61M derived: sum of 2 quarters · filed 2014-03-03 | -$50.71M derived: sum of 3 quarters · filed 2014-03-03 | -$56.53M derived: sum of 4 quarters · filed 2014-03-03 | -$168.67M 10-Q · filed 2012-05-03 | |||||||||||
| 2011-12-31 | -$13.75M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$24.85M derived: sum of 2 quarters · filed 2014-03-03 | -$30.67M derived: sum of 3 quarters · filed 2014-03-03 | -$38.84M 10-K · filed 2014-03-03 | -$142.81M 10-K · filed 2012-02-29 | |||||||||||
| 2011-09-30 | -$11.10M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-08 | -$16.92M derived: sum of 2 quarters · filed 2012-11-08 | -$25.09M 10-Q · filed 2012-11-08 | -$30.87M derived: sum of 4 quarters · filed 2013-03-18 | -$129.06M 10-Q · filed 2011-11-03 | |||||||||||
| 2011-06-30 | -$5.82M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-28 | -$13.99M 10-Q/A · filed 2012-08-28 | -$19.77M derived: sum of 3 quarters · filed 2013-03-18 | -$25.58M derived: sum of 4 quarters · filed 2013-03-18 | -$117.96M 10-Q/A · filed 2011-08-09 | |||||||||||
| 2011-03-31 | -$8.17M 10-Q · filed 2012-05-03 | -$13.95M derived: sum of 2 quarters · filed 2013-03-18 | -$19.76M derived: sum of 3 quarters · filed 2013-03-18 | |||||||||||||
| 2010-12-31 | -$5.78M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$11.59M derived: sum of 2 quarters · filed 2013-03-18 | -$19.69M 10-K · filed 2013-03-18 | |||||||||||||
| 2010-09-30 | -$5.81M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-03 | -$13.91M 10-Q · filed 2011-11-03 | -$98.19M 10-Q · filed 2011-08-01 | |||||||||||||
| 2010-06-30 | -$8.10M 10-Q/A · filed 2011-08-09 | |||||||||||||||
| 2009-12-31 | -$3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$12.29M 10-K · filed 2012-02-29 | ||||||||||||||
| 2009-09-30 | -$8.90M 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |